UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Islay Capital Management LLC

Islay Capital Management LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,847 shares of the healthcare conglomerate’s stock after buying an additional 119 shares during the quarter. UnitedHealth Group comprises approximately 1.0% of Islay Capital Management LLC’s portfolio, making the stock its 28th largest position. Islay Capital Management LLC’s holdings in UnitedHealth Group were worth $1,440,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $32,000. Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $40,000. Finally, Legacy Investment Solutions LLC purchased a new position in shares of UnitedHealth Group during the third quarter worth $57,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Down 2.9 %

Shares of NYSE UNH opened at $524.94 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The business has a 50-day moving average price of $509.24 and a 200 day moving average price of $542.37. The stock has a market cap of $480.17 billion, a PE ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.83 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on UNH shares. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.